Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis i

Journal of Inherited Metabolic Disease

Volumn 33, Issue 2, 2010, Pages 141-150

  Tomatsu, Shunji ^a   Montaño, Adriana M ^a   Oguma, Toshihiro ^b   Dung, Vu Chi ^a   Oikawa, Hirotaka ^a   De Carvalho, Talita Giacomet ^a   Gutiérrez, María L ^a   Yamaguchi, Seiji ^c   Suzuki, Yasuyuki ^d   Fukushi, Masaru ^e   Sakura, Nobuo ^f   Barrera, Luis ^g   Kida, Kazuhiro ^h   Kubota, Mitsuru ^h   Orii, Tadao ^d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e Sapporo City Institute of Public Health   (Japan)

^f Suzugamine Women's College   (Japan)

^g PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^h HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DERMATAN SULFATE; ENZYME; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPLACEMENT; FEMALE; HUMAN; HURLER SYNDROME; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PATIENT MONITORING; SCHEIE SYNDROME; SCREENING; URINALYSIS; URINE LEVEL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DERMATAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARITIN SULFATE; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; MUCOPOLYSACCHARIDOSIS I; NEONATAL SCREENING; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 77953230038     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9036-3     Document Type: Article

References (48)

1. Y An SP Young PS Kishnani DS Millington AD AmalWtano Corz YT Chen 2005 Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease Mol Genet Metab 85 247 254 10.1016/j.ymgme.2005.03.010 1:CAS:528:DC%2BD2MXmvVCntbs%3D 15886040 (Pubitemid 41074107)
2. CE Beesley EP Young N Finnegan M Jackson K Mills A Vellodi M Cleary BG Winchester 2009 Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry Mol Genet Metab 96 218 224 10.1016/j.ymgme.2008.12.002 1:CAS:528: DC%2BD1MXjt1agur0%3D 19153055
3. S Bjornsson 1993 Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue Anal Biochem 210 282 291 10.1006/abio.1993.1197 1:STN:280:DyaK3s3ovF2msw%3D%3D 8512063 (Pubitemid 23171019)
4. S Blanchard M Sadilek CR Scott F Turecek MH Gelb 2008 Tandem mass spectrometry for the direct assay of lysosomal enzymes in DBS: application to screening newborns for mucopolysaccharidosis I Clin Chem 54 2067 2070 10.1373/clinchem.2008.115410 1:CAS:528:DC%2BD1MXjtFeitg%3D%3D 19042989 (Pubitemid 352774043)
5. S Byers T Rozaklis LK Brumfield E Ranieri JJ Hopwood 1998 Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS Mol Genet Metab 65 282 290 10.1006/mgme.1998.2761 1:CAS:528:DyaK1MXltlWmsA%3D%3D 9889015 (Pubitemid 29029544)
6. H Church K Tylee A Cooper M Thornley J Mercer E Wraith T Carr A O'Meara RF Wynn 2007 Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): Implications for functional outcome after transplant in metabolic disease Bone Marrow Transplant 39 207 210 10.1038/sj.bmt.1705569 1:CAS:528:DC%2BD2sXhsV2isbw%3D 17220904
7. G Civallero K Michelin J de Mari M Viapiana M Burin JC Coelho R Giugliani 2006 Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases Clin Chim Acta 372 1-2 98 102 10.1016/j.cca.2006.03.029 1:CAS:528: DC%2BD28XovVSktrg%3D 16712827 (Pubitemid 44286767)
8. A Crawley SL Ramsay S Byers JJ Hopwood PJ Meikle 2004 Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry Pediatr Res 55 585 591 10.1203/01.PDR.0000113789. 30640.5C 1:CAS:528:DC%2BD2cXhvFOjur8%3D 14711884 (Pubitemid 38405844)
9. P Di Natale GR Villani R Parini M Scarpa G Parenti G Pontarelli M Grosso G Sersale R Tomanin M Sibilio R Barone A Fiumara 2008 Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease Biotechnol Appl Biochem 49 Pt 3 219 223 10.1042/BA20070093 17672828 (Pubitemid 351579074)
10. RW Farndale DJ Buttle AJ Barrett 1986 Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue Biochim Biophys Acta 883 173 177 1:CAS:528:DyaL28Xls1yhsrs%3D 3091074
11. R Froissart I Moreira da Silva N Guffon D Bozon I Maire 2002 Mucopolysaccharidosis type II-genotype/phenotype aspects Acta Paediatr Suppl 91 82 87 10.1080/080352502762457996 1:STN:280:DC%2BD3s%2Fmt1WnsQ%3D%3D 12572848
12. M Fuller T Rozaklis SL Ramsay JJ Hopwood PJ Meikle 2004 Disease-specific markers for the mucopolysaccharidoses Pediatr Res 56 733 738 10.1203/01.PDR.0000141987.69757.DD 1:CAS:528:DC%2BD2cXotlagtLw%3D 15347771 (Pubitemid 39403398)
13. M Fuller DA Brooks M Evangelista LK Hein JJ Hopwood PJ Meikle 2005 Prediction of neuropathology in mucopolysaccharidosis I patients Mol Genet Metab 84 18 24 10.1016/j.ymgme.2004.09.004 1:CAS:528:DC%2BD2MXis1Srug%3D%3D 15639191 (Pubitemid 40082601)
14. MP Gallegos-Arreola MV Machorro-Lazo SE Flores-Martinez GM Zuniga-Gonzalez LE Figuera A Gonzalez-Noriega J Sanchez-Corona 2000 Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses Arch Med Res 31 505 510 10.1016/S0188-4409(00)00104-1 1:CAS:528:DC%2BD3MXhsFWqtro%3D 11179586 (Pubitemid 32114182)
15. MH Gelb F Turecek CR Scott NA Chamoles 2006 Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders J Inherit Metab Dis 29 2-3 397 404 10.1007/s10545-006-0265-4 1:CAS:528:DC%2BD28XlsV2ltbc%3D 16763908 (Pubitemid 43880641)
16. EW Gold 1981 The quantitative spectrophotometric estimation of total sulfated glycosaminoglycan levels. Formation of soluble alcian blue complexes Biochim Biophys Acta 673 408 415 1:CAS:528:DyaL3MXhslSntb4%3D 6784773
17. P Harmatz CB Whitley L Waber R Pais R Steiner B Plecko P Kaplan J Simon E Butensky JJ Hopwood 2004 Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) J Pediatr 144 574 580 10.1016/j.jpeds.2004.03.018 1:CAS:528:DC%2BD2cXjs1Wnsb0%3D 15126989 (Pubitemid 38594756)
18. P Harmatz D Ketteridge R Giugliani N Guffon EL Teles MC Miranda ZF Yu SJ Swiedler JJ Hopwood 2005 Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase Pediatrics 115 e681 e689 10.1542/peds.2004-1023 15930196 (Pubitemid 43843141)
19. P Harmatz R Giugliani I Schwartz N Guffon EL Teles MC Miranda JE Wraith M Beck L Arash M Scarpa ZF Yu J Wittes KI Berger MS Newman AM Lowe E Kakkis SJ Swiedler 2006 MPS VI Phase 3 Study Group, enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blinded, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or RHASB) and follow-on, open-label extension study J Pediatr 148 533 539 10.1016/j.jpeds.2005.12.014 1:CAS:528:DC%2BD28XjvVGmtLo%3D 16647419 (Pubitemid 44419350)
20. LK Hein PJ Meikle CJ Dean MR Bockmann D Auclair JJ Hopwood DA Brooks 2005 Development of an assay for the detection of Mucopolysaccharidosis type VI patients using dried blood spots Clin Chim Acta 353 67 74 10.1016/j.cccn.2004. 10.009 1:CAS:528:DC%2BD2MXhtV2nu78%3D 15698592 (Pubitemid 40215432)
21. ED Kakkis MF McEntee EF Neufeld AJ Jonas RM Shull SA Kania 1994 Enzyme replacement in a canine model of Hurler syndrome Proc Natl Acad Sci U S A 91 12937 12941 10.1073/pnas.91.26.12937 7809150
22. M Karlsson I Edfors-Lilja S Bjornsson 2000 Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents Anal Biochem 286 51 58 10.1006/abio.2000.4767 1:CAS:528:DC%2BD3cXntlKrsLk%3D 11038273
23. King B, Savas P, Fuller M, Hopwood J, Hemsley K (2006) Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA. Mol Genet Metab 87:107-112
24. Langford-Smith K, Arasaradnam M, Wraith JE, Wynn R, Bigger BW (2009) Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. Mol Genet Metab [Epub ahead of print]
25. T Litjens DA Brooks C Peters GJ Gibson JJ Hopwood 1996 Identification, expression, and biochemical characterization of N-acetylgalactosamine-4- sulfatase mutations and relationship with clinical phenotype in MPS-VI patients Am J Hum Genet 58 1127 1134 1:CAS:528:DyaK28Xjslaktrs%3D 8651289
26. P Mabe A Valiente V Soto V Cornejo E Raimann 2004 Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and berry spot tests Clin Chim Acta 345 135 140 10.1016/j.cccn.2004.03.015 1:CAS:528:DC%2BD2cXkvVKksrc%3D 15193988 (Pubitemid 38749182)
27. PJ Meikle DJ Grasby CJ Dean DL Lang M Bockmann AM Whittle MJ Fietz H Simonsen M Fuller DA Brooks JJ Hopwood 2006 Newborn screening for lysosomal storage disorders Mol Genet Metab 88 307 314 10.1016/j.ymgme.2006.02.013 1:CAS:528:DC%2BD28Xns1Kjsrk%3D 16600651 (Pubitemid 44107765)
28. AM Montaño H Oikawa NT Tomatsu C Vogler MA Gutierrez T Oguma Y Tan JH Grubb VC Dung A Ohashi K Miyamoto T Orii Y Yoneda WS Sly 2008 Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice Mol Genet Metab 94 178 189 10.1016/j.ymgme.2008.01.007 18359257
29. J Muenzer JC Lamsa A Garcia J Dacosta J Garcia DA Treco 2002 Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report Acta Paediatr Suppl 91 98 99 10.1080/080352502762458012 1:STN:280:DC%2BD3s%2Fmt1Wntw%3D%3D 12572850
30. J Muenzer JE Wraith M Beck R Giugliani P Harmatz CM Eng A Vellodi R Martin U Ramaswami M Gucsavas-Calikoglu S Vijayaraghavan S Wendt A Puga B Ulbrich M Shinawi M Cleary D Piper A Conway A Kimura 2006 A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) Genet Med 8 465 473 10.1097/01.gim.0000232477.37660.fb 1:CAS:528:DC%2BD28XotFWqs7c%3D 16912578
31. T Oguma S Tomatsu O Okazaki 2007 Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry Biomed Chromatogr 21 356 362 10.1002/bmc.760 1:CAS:528: DC%2BD2sXltFaqt7k%3D 17236248 (Pubitemid 46567193)
32. T Oguma S Tomatsu AM Montaño O Okazaki 2007 Analytical method for determination of disaccharides derived from keratan, heparan and dermatan sulfates in human serum and plasma by high-performance liquid chromatography / turbo-ionspray ionization tandem mass spectrometry Analytical Biochem 368 79 86 10.1016/j.ab.2007.05.016 1:CAS:528:DC%2BD2sXotVWlsbY%3D (Pubitemid 47058433)
33. SL Ramsay PJ Meikle JJ Hopwood 2003 Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry Mol Genet Metab 78 193 204 10.1016/S1096-7192(03)00018-0 1:CAS:528:DC%2BD3sXitVKntrc%3D 12649064 (Pubitemid 36332020)
34. SL Ramsay EI Maire C Bindloss M Fuller M Piraud JJ Hopwood PJ Meikle 2004 Determination of oligosaccharides & glycolipids in amniotic fluids by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases Mol Genet Metab 83 231 238 10.1016/j.ymgme.2004.07. 015 1:CAS:528:DC%2BD2cXpslCru7Y%3D 15542394 (Pubitemid 39473065)
35. DR Randall GB Sinclair KE Colobong E Hetty LA Clarke 2006 Heparin cofactor II thrombin complex in MPS I: a biomarker of MPS disease Mol Genet Metab 88 235 243 10.1016/j.ymgme.2006.01.005 1:CAS:528:DC%2BD28Xms1agu7c%3D 16497528 (Pubitemid 43963434)
36. DR Randall KE Colobong H Hemmelgarn GB Sinclair E Hetty A Thomas OA Bodamer B Volkmar PM Fernhoff R Casey AK Chan G Mitchell S Stockler S Melancon T Rupar LA Clarke 2008 Heparin cofactor II-thrombin complex: a biomarker of MPS disease Mol Genet Metab 94 456 461 10.1016/j.ymgme.2008.05.001 1:CAS:528:DC%2BD1cXosVOnur0%3D 18511319
37. TP Roddy BC Nelson CC Sung S Araghi D Wilkens XK Zhang JJ Thomas SM Richards 2004 Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy Clin Chem 51 237 240 10.1373/clinchem.2004.038323 15514097
38. NJ Terlato GF Cox 2003 Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature Genet Med 5 286 294 10.1097/01.GIM.0000078027.83236.49 1:CAS:528:DC%2BD3sXlsVKgu70%3D 12865757 (Pubitemid 36998686)
39. S Tomatsu K Okamura T Taketani KO Orii T Nishioka MA Gutierrez S Velez-Castrillon AA Fachel JH Grubb A Cooper M Thornley E Wraith LA Barrera R Giugliani IV Schwartz GS Frenking M Beck SG Kircher E Paschke S Yamaguchi K Ullrich K Isogai Y Suzuki T Orii N Kondo M Creer A Noguchi 2004 Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA Pediatr Res 55 592 597 10.1203/01.PDR.0000113767.60140.E9 1:CAS:528: DC%2BD2cXhvFOjtbc%3D 14711889 (Pubitemid 38405845)
40. S Tomatsu K Okamura T Taketani KO Orii T Nishioka MA Gutierrez S Velez-Castrillon AA Fachel JH Grubb A Cooper M Thornley E Wraith LA Barrera R Giugliani IV Schwartz GS Frenking M Beck SG Kircher E Paschke S Yamaguchi K Ullrich K Isogai Y Suzuki T Orii N Kondo M Creer A Noguchi 2005 Keratan sulfate levels in mucopolysaccharidoses and mucolipidoses J Inherit Metab Dis 28 187 202 10.1007/s10545-005-5673-3 1:CAS:528:DC%2BD2MXjvFKqsLw%3D 15877208 (Pubitemid 40723887)
41. S Tomatsu MA Gutierrez T Ishimaru OM Pena AM Montano H Maeda S Velez-Castrillon T Nishioka AA Fachel A Cooper M Thornley E Wraith LA Barrera LS Laybauer R Giugliani IV Schwartz GS Frenking M Beck SG Kircher E Paschke S Yamaguchi K Ullrich K Isogai Y Suzuki T Orii A Noguchi 2005 Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses J Inherit Metab Dis 28 743 757 10.1007/s10545-005-0069-y 1:CAS:528:DC%2BD2MXpvVWqurs%3D 16151906 (Pubitemid 41349262)
42. S Tomatsu AM Montaño A Ohashi H Oikawa T Oguma VC Dung T Nishioka T Orii WS Sly 2008 Enzyme replacement therapy in a murine model of Morquio A syndrome Hum Mol Genet 17 815 824 10.1093/hmg/ddm353 1:CAS:528: DC%2BD1cXis1Gltb8%3D 18056156 (Pubitemid 351359698)
43. Tomatsu S, Montaño AM, Oguma T, Dun VC, Oikawa H, de Carvalho TG, Gutiérrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Barrera L, Orii T. Validation of keratan sulfate level in Mucopolysaccharidosis IVA by liquid tandem mass spectrometry method. Inherit Metab Dis (in press)
44. D Wang B Eadala M Sadilek NA Chamoles F Turecek CR Scott MH Gelb 2005 Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns Clin Chem 51 898 900 10.1373/clinchem.2004. 047167 1:CAS:528:DC%2BD2MXjvVKjsrk%3D 15695324 (Pubitemid 40577928)
45. D Wang T Wood M Sadilek CR Scott F Turecek MH Gelb 2007 Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease) Clin Chem 53 137 140 10.1373/clinchem.2006.077263 1:CAS:528:DC%2BD2sXmsFGhsA%3D%3D 17082248 (Pubitemid 46047775)
46. CB Whitley MD Ridnour KA Draper CM Dutton JP Neglia 1989 Diagnostic test for mucopolysaccharidosis I. Direct method for quantifying excessive urinary glycosaminoglycan excretion Clin Chem 35 374 379 1:CAS:528:DyaL1MXhs12ls7s%3D 2493341
47. CB Whitley RC Spielmann G Herro SS Teragawa 2002 Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe Mol Genet Metab 75 56 64 10.1006/mgme.2001.3271 1:CAS:528:DC%2BD38Xpt1WnsA%3D%3D 11825064 (Pubitemid 34971535)
48. JE Wraith LA Clarke M Beck EH Kolodny GM Pastores J Muenzer BKI DM SJ Swiedler ED Kakkis T Braakman E Chadbourne K Walton-Bowen GF Cox 2004 Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human a-l-iduronidase (Laronidase) J Pediatr 144 581 588 10.1016/j.jpeds.2004.01.046 1:CAS:528:DC%2BD2cXjs1Wnsbg%3D 15126990 (Pubitemid 38594757)